TY - JOUR
T1 - Effects of inspiratory muscle training on lung function parameter in swimmers
T2 - a systematic review and meta-analysis
AU - Carvajal-Tello, Nathali
AU - Ortega, José Guillermo
AU - Caballero-Lozada, Andrés Fabricio
AU - Devia-Quiñonez, María Juliana
AU - González-Calzada, Isabella
AU - Rojas-Hernández, Daniela
AU - Segura-Ordoñez, Alejandro
N1 - Publisher Copyright:
2024 Carvajal-Tello, Ortega, Caballero-Lozada, Devia-Quiñonez, González-Calzada, Rojas-Hernández and Segura-Ordoñez.
PY - 2024
Y1 - 2024
N2 - Background: This systematic review and meta-analysis aimed to assess the impact of inspiratory muscle training (IMT) on lung function parameters (MIP, MEP, FEV1, and FVC) between both elite and non-elite swimmers. Methods: We searched for controlled clinical trials (CCT) and prospective longitudinal studies (PLS) in elite and non-elite swimmers following an inspiratory muscle training (IMT) protocol with a standardized device, published between 2012 and 2023. The databases used in the search were PubMed, Science Direct, Scopus, Springer, Cochrane Central Register of Controlled Trials, and Google Scholar. The primary outcome assessed was the impact of IMT on lung function parameters, including MIP, MEP, FEV1, and FVC. Results: We selected 13 articles involving 277 subjects aged 11–21 years, with 61.4% being male, and 84.6% being elite swimmers. The most commonly used IMT device was the PowerBreathe®, prescribed for 3–12 weeks, 1–2 sessions per day, 3–6 times per week, with 30 repetitions, starting at 50% of MIP and progressing up to 80%. The meta-analysis showed that IMT was associated with a higher MIP (MD = 29.35 cmH2O, 95% CI: 13.04–45.65 cmH2O, p < 0.01) without affecting FEV1 and FVC. Conclusion: The swimmers that used IMT improved muscle strength, specifically MIP, without changes in MEP, FEV1, and FVC.
AB - Background: This systematic review and meta-analysis aimed to assess the impact of inspiratory muscle training (IMT) on lung function parameters (MIP, MEP, FEV1, and FVC) between both elite and non-elite swimmers. Methods: We searched for controlled clinical trials (CCT) and prospective longitudinal studies (PLS) in elite and non-elite swimmers following an inspiratory muscle training (IMT) protocol with a standardized device, published between 2012 and 2023. The databases used in the search were PubMed, Science Direct, Scopus, Springer, Cochrane Central Register of Controlled Trials, and Google Scholar. The primary outcome assessed was the impact of IMT on lung function parameters, including MIP, MEP, FEV1, and FVC. Results: We selected 13 articles involving 277 subjects aged 11–21 years, with 61.4% being male, and 84.6% being elite swimmers. The most commonly used IMT device was the PowerBreathe®, prescribed for 3–12 weeks, 1–2 sessions per day, 3–6 times per week, with 30 repetitions, starting at 50% of MIP and progressing up to 80%. The meta-analysis showed that IMT was associated with a higher MIP (MD = 29.35 cmH2O, 95% CI: 13.04–45.65 cmH2O, p < 0.01) without affecting FEV1 and FVC. Conclusion: The swimmers that used IMT improved muscle strength, specifically MIP, without changes in MEP, FEV1, and FVC.
KW - athletes
KW - muscle strength
KW - respiratory muscles
KW - sports performance
KW - swimming
UR - http://www.scopus.com/inward/record.url?scp=85205366253&partnerID=8YFLogxK
U2 - 10.3389/fspor.2024.1429902
DO - 10.3389/fspor.2024.1429902
M3 - Review article
AN - SCOPUS:85205366253
SN - 2624-9367
VL - 6
JO - Frontiers in Sports and Active Living
JF - Frontiers in Sports and Active Living
M1 - 1429902
ER -